419 related articles for article (PubMed ID: 17952650)
1. Cannabinoids and gliomas.
Velasco G; Carracedo A; Blázquez C; Lorente M; Aguado T; Haro A; Sánchez C; Galve-Roperh I; Guzmán M
Mol Neurobiol; 2007 Aug; 36(1):60-7. PubMed ID: 17952650
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids as potential new therapy for the treatment of gliomas.
Parolaro D; Massi P
Expert Rev Neurother; 2008 Jan; 8(1):37-49. PubMed ID: 18088200
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Guzmán M
Neuropharmacology; 2004 Sep; 47(3):315-23. PubMed ID: 15275820
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Blázquez C; Carracedo A; Salazar M; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Neuropharmacology; 2008 Jan; 54(1):235-43. PubMed ID: 17675107
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Blázquez C; Salazar M; Carracedo A; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Cancer Res; 2008 Mar; 68(6):1945-52. PubMed ID: 18339876
[TBL] [Abstract][Full Text] [Related]
6. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
Guzmán M; Duarte MJ; Blázquez C; Ravina J; Rosa MC; Galve-Roperh I; Sánchez C; Velasco G; González-Feria L
Br J Cancer; 2006 Jul; 95(2):197-203. PubMed ID: 16804518
[TBL] [Abstract][Full Text] [Related]
7. Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities.
Peeri H; Koltai H
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454080
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid signaling in glioma cells.
Ellert-Miklaszewska A; Ciechomska I; Kaminska B
Adv Exp Med Biol; 2013; 986():209-20. PubMed ID: 22879071
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas.
Rocha FC; Dos Santos Júnior JG; Stefano SC; da Silveira DX
J Neurooncol; 2014 Jan; 116(1):11-24. PubMed ID: 24142199
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid Signaling in Glioma Cells.
Ellert-Miklaszewska A; Ciechomska IA; Kaminska B
Adv Exp Med Biol; 2020; 1202():223-241. PubMed ID: 32034716
[TBL] [Abstract][Full Text] [Related]
11. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
Lorente M; Torres S; Salazar M; Carracedo A; Hernández-Tiedra S; Rodríguez-Fornés F; García-Taboada E; Meléndez B; Mollejo M; Campos-Martín Y; Lakatosh SA; Barcia J; Guzmán M; Velasco G
Cell Death Differ; 2011 Jun; 18(6):959-73. PubMed ID: 21233844
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids and Cancer.
Velasco G; Sánchez C; Guzmán M
Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
[TBL] [Abstract][Full Text] [Related]
15. [The endocannabinoid system as a target for the development of new drugs for cancer therapy].
Bifulco M; Di Marzo V
Recenti Prog Med; 2003 May; 94(5):194-8. PubMed ID: 12723496
[TBL] [Abstract][Full Text] [Related]
16. A Review of the Therapeutic Antitumor Potential of Cannabinoids.
Bogdanović V; Mrdjanović J; Borišev I
J Altern Complement Med; 2017 Nov; 23(11):831-836. PubMed ID: 28799775
[TBL] [Abstract][Full Text] [Related]
17. The use of cannabinoids as anticancer agents.
Velasco G; Hernández-Tiedra S; Dávila D; Lorente M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():259-66. PubMed ID: 26071989
[TBL] [Abstract][Full Text] [Related]
18. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
19. Future Aspects for Cannabinoids in Breast Cancer Therapy.
Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
[TBL] [Abstract][Full Text] [Related]
20. Cancer Treatment: Preclinical & Clinical.
Abrams DI; Velasco G; Twelves C; Ganju RK; Bar-Sela G
J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):107-113. PubMed ID: 34850894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
